Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Thorax|August 28, 2025
Interferon gamma applied ex vivo restores function to neutrophils from critically ill patientsCameron J Lake, Jonathan Scott, Marie-Hélène Ruchaud-Sparagano, et al.
The Journal of Allergy and Clinical Immunology|September 22, 2015
Exchange protein directly activated by cyclic AMP (EPAC) activation reverses neutrophil dysfunction induced by β2-agonists, corticosteroids, and critical illnessJonathan Scott, Graham J Harris, Emma M Pinder, et al.
Thrombosis Research|June 1, 2023
Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsisKathryn M Musgrave, Jonathan Scott, Wezi Sendama, et al.
Thorax|August 2, 2018
Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosisEmma M Pinder, Anthony J Rostron, Thomas P Hellyer, et al.
Wellcome Open Research|November 16, 2022
Development and implementation of a customised rapid syndromic diagnostic test for severe pneumoniaVilas Navapurkar, Josefin Bartholdson Scott, Mailis Maes, et al.
Nature Communications|December 8, 2021
Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2Catherine F Hatton, Rachel A Botting, Maria Emilia Dueñas, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 30, 2021
Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15Irene Cimino, Hanna Kim, Y C Loraine Tung, et al.
Thorax|October 10, 2014
Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumoniaThomas P Hellyer, Andrew Conway Morris, Daniel F McAuley, et al.
The Lancet. Respiratory Medicine|December 8, 2019
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluationThomas P Hellyer, Daniel F McAuley, Timothy S Walsh, et al.
Pageof 8